Besides, many cancers develop unresponsiveness to IFN-I in order to overcome its cytostatic effects by downmodulating its receptor chains, upregulating the negative regulators of the JAK-STAT pathway such as SOCS1, or reducing the expression of STAT1 [241,242]. The gene discussed is STAT1; the disease is cancer.